# The Blincyto market size has shown robust growth.

*biotech · news · 2026-05-01 · GlobeNewswire*

## Key points

- Blincyto market size is expected to grow from $0.81M in 2025 to $1.08M by 2030.
- In 2024, Blincyto received FDA approval for B-cell precursor acute lymphoblastic leukemia treatment.
- Tariffs have increased imported raw material costs, affecting oncology treatment affordability in Asia-Pacific and Latin America.
- Asia Pacific is anticipated to experience the fastest Blincyto market growth during the forecast period.

**Companies:** Amgen Inc.
**Countries:** United States, United Kingdom

[Read the full story on GlobeNewswire](https://www.globenewswire.com/news-release/2026/05/01/3285890/28124/en/blincyto-blinatumomab-amgen-market-research-report-2026-epidemiology-pipeline-analysis-market-insights-forecasts-2020-2025-2025-2030f-2035f.html)

---

Canonical: https://newsio.io/n/459c32ad-4f24-46ae-9f61-d81ba9a0da0d/the-blincyto-market-size-has-shown-robust-growth-the-forecast-predicts-the-marke
Summarized by Newsio from GlobeNewswire. https://newsio.io/how-it-works